HomeCompareOCPNF vs MRK

OCPNF vs MRK: Dividend Comparison 2026

OCPNF yields 1.60% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OCPNF wins by $25.59M in total portfolio value· pulled ahead in Year 3
10 years
OCPNF
OCPNF
● Live price
1.60%
Share price
$9.33
Annual div
$0.15
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.65M
Annual income
$22,904,855.92
Full OCPNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — OCPNF vs MRK

📍 OCPNF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOCPNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OCPNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OCPNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OCPNF
Annual income on $10K today (after 15% tax)
$136.31/yr
After 10yr DRIP, annual income (after tax)
$19,469,127.53/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, OCPNF beats the other by $19,460,799.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OCPNF + MRK for your $10,000?

OCPNF: 50%MRK: 50%
100% MRK50/50100% OCPNF
Portfolio after 10yr
$12.85M
Annual income
$11,457,327.03/yr
Blended yield
89.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

OCPNF
No analyst data
Altman Z
3.0
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OCPNF buys
0
MRK buys
0
No recent congressional trades found for OCPNF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOCPNFMRK
Forward yield1.60%2.76%
Annual dividend / share$0.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$25.65M$56.8K
Annual income after 10y$22,904,855.92$9,798.13
Total dividends collected$25.41M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OCPNF vs MRK ($10,000, DRIP)

YearOCPNF PortfolioOCPNF Income/yrMRK PortfolioMRK Income/yrGap
1$11,021$320.73$11,206$366.19$185.00MRK
2$12,453$660.69$12,650$502.35$197.00MRK
3← crossover$14,720$1,395.40$14,407$694.19+$313.00OCPNF
4$18,833$3,083.07$16,585$967.82+$2.2KOCPNF
5$27,525$7,373.14$19,342$1,363.89+$8.2KOCPNF
6$49,593$20,141.65$22,913$1,947.19+$26.7KOCPNF
7$120,897$67,832.60$27,662$2,823.89+$93.2KOCPNF
8$438,446$309,085.52$34,159$4,173.35+$404.3KOCPNF
9$2,564,328$2,095,191.15$43,337$6,308.80+$2.52MOCPNF
10$25,648,687$22,904,855.92$56,776$9,798.13+$25.59MOCPNF

OCPNF vs MRK: Complete Analysis 2026

OCPNFStock

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

Full OCPNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this OCPNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OCPNF vs SCHDOCPNF vs JEPIOCPNF vs OOCPNF vs KOOCPNF vs MAINOCPNF vs JNJOCPNF vs ABBVOCPNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.